These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11843065)

  • 1. Management of enterochromaffin-like gastric carcinoid tumour metastasized to the liver.
    Kouraklis G; Misiakos E; Glinavou A; Raftopoulos J; Karatzas G
    Scand J Gastroenterol; 2002 Feb; 37(2):246-8. PubMed ID: 11843065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodality treatment for gastric carcinoid tumor with liver metastases.
    Caplin ME; Hodgson HJ; Dhillon AP; Begent R; Buscombe J; Dick R; Rolles K; Burroughs AK
    Am J Gastroenterol; 1998 Oct; 93(10):1945-8. PubMed ID: 9772061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Individual therapeutic procedure in metastatic carcinoid of the small intestine].
    Barthel A; Leonhardt U; Stöckmann F; Ramadori G
    Leber Magen Darm; 1996 May; 26(3):164, 167-9. PubMed ID: 8709831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A long-term survival case of gastric carcinoid with multiple liver metastasis].
    Sasaki Y; Hoshino H; Nishimura D; Seki Y; Morita K; Katada N; Kato K
    Nihon Shokakibyo Gakkai Zasshi; 2001 Mar; 98(3):290-4. PubMed ID: 11280906
    [No Abstract]   [Full Text] [Related]  

  • 5. Gastric enterochromaffin-like-cell tumor with liver and splenic metastases.
    Eriguchi N; Aoyagi S; Hara M; Sakai T; Imayama H; Tanaka E; Hashimoto M; Imamura I; Kage M
    J Gastroenterol; 1999 Jun; 34(3):383-6. PubMed ID: 10433017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum chromogranin A reflects regression of metastatic carcinoid during prolonged octreotide treatment.
    Pregun I; Gergics P; Dabasi G; Igaz P; Racz K; Tulassay Z
    Eur J Gastroenterol Hepatol; 2009 Apr; 21(4):476-7. PubMed ID: 19382304
    [No Abstract]   [Full Text] [Related]  

  • 7. Carcinoid of the pancreas.
    Migliori M; Tomassetti P; Lalli S; Casadei R; Santini D; Corinaldesi R; Gullo L
    Pancreatology; 2002; 2(2):163-6. PubMed ID: 12123097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoid tumour management in haemodialysis: a case report.
    Burke MT; Gray NA
    Nephrology (Carlton); 2012 Feb; 17(2):198. PubMed ID: 22257155
    [No Abstract]   [Full Text] [Related]  

  • 9. Complete histological regression of metastatic carcinoid tumour after treatment with octreotide.
    Imtiaz KE; Monteith P; Khaleeli A
    Clin Endocrinol (Oxf); 2000 Dec; 53(6):755-8. PubMed ID: 11155099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated hepatic arterial chemoembolization therapy for management of a patient with metastatic carcinoid tumors of the liver.
    Nakaoka R; Kamisako T; Shiomi M; Kudo M
    Am J Gastroenterol; 2000 Jul; 95(7):1842-3. PubMed ID: 10926003
    [No Abstract]   [Full Text] [Related]  

  • 11. [The treatment of carcinoid of the small intestine with octreotide and alpha-interferon. A call for participation in a randomized study].
    Ahrén B
    Dtsch Med Wochenschr; 1996 May; 121(22):744-5. PubMed ID: 8646989
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatic artery embolization for treatment of patients with metastatic carcinoid tumors: a commentary.
    Norton JA; Kerlan RK
    Cancer J; 2003; 9(4):241-3. PubMed ID: 12967132
    [No Abstract]   [Full Text] [Related]  

  • 13. Neurokinin A monitoring of response to interferon alpha in a patient with an advanced small bowel neuroendocrine tumour uncontrolled by somatostatin analogue therapy.
    Ardill JE; Johnston BT; McCance DR; Eatock M
    Ann Clin Biochem; 2017 Mar; 54(2):297-301. PubMed ID: 27638929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoid tumors of the gastrointestinal tract. A review and the Duke University institutional overview.
    Onaitis M; White R; Tyler D
    Minerva Chir; 2003 Feb; 58(1):1-8. PubMed ID: 12692491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Octreotide as a rapid and effective painkiller for metastatic carcinoid tumor.
    Katai M; Sakurai A; Inaba H; Ikeo Y; Yamauchi K; Hashizume K
    Endocr J; 2005 Apr; 52(2):277-80. PubMed ID: 15863961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of metastatic carcinoid with the somatostatin analog octreotide and with recombinant interferon alfa 2b].
    Linkesch M; Kuzmits R; Geyer G
    Wien Klin Wochenschr; 1989 Jun; 101(13):455-7. PubMed ID: 2763566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric carcinoid type I tumour: new diagnostic and therapeutic method.
    Prommegger R; Bale R; Ensinger C; Sauper T; Profanter C; Knoflach M; Moncayo R
    Eur J Gastroenterol Hepatol; 2003 Jun; 15(6):705-7. PubMed ID: 12840685
    [No Abstract]   [Full Text] [Related]  

  • 18. Follow-up of patients with ECL cell-derived tumours.
    Sagatun L; Fossmark R; Jianu CS; Qvigstad G; Nordrum IS; Mjønes P; Waldum HL
    Scand J Gastroenterol; 2016 Nov; 51(11):1398-405. PubMed ID: 27309188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical images in gastrology. Carcinoid tumor metastatic liver].
    Cortés-Espinosa T; de la Cruz-Guillén A; Manzano-Cortés H
    Rev Gastroenterol Mex; 2008; 73(4):247. PubMed ID: 19666276
    [No Abstract]   [Full Text] [Related]  

  • 20. The tumour vanishes.
    Todd JF; Meeran K
    Clin Endocrinol (Oxf); 2000 Dec; 53(6):663-4. PubMed ID: 11155085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.